decisionhealth Newsletters, Coder Pink Sheets - 2004 Issue 10 (October)
Hemophilia drug gets new HCPCS code
Subscribe or sign in to view the full article.
Article Overview
This article explains a Medicare coding update affecting hemophilia A treatment billing. It covers a new HCPCS code assignment, the effective date referenced by CMS, and related claim-processing guidance involving re-coding and a billing modifier. The piece is relevant to providers, coders, and billing staff working with hemophilia-related drug claims and Medicare office submissions.
Why This Topic Matters
It helps billing teams recognize that Medicare issued a new coding instruction for a hemophilia drug and that older or alternate claim submissions may need attention for affected dates of service.
What You Will Learn
- What Medicare coding change was issued for a hemophilia A drug
- Which general claim-processing issues the article addresses
- How the article frames the timing of the coding update
- What types of providers and billing staff may need to review claims
Who Should Read This
- Medical coders
- Billing staff
- Claims reviewers
- Hemophilia treatment providers
- Medicare billers
Codes Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com